Latest From Biotech Now

Indices, IPOs, and New Drug Approvals – Update July 6th 2012

Index-Perfomance-June-2012-thumb

1. Stock Performance. The Nasdaq Biotech Index (NBI) continued on its path of outperforming the market, up 24.6 percent and increasing its Year-to-Date (YTD) lead over the S&P 500 which is up 8.3 percent. The Amex Biotech Index (BTK) closed out June up a hefty 34.6 percent YTD: 2. IPOs: Tesaro, Inc. (TSRO) was June’s sole U.S. IPO, raising $81M.  The company was formed just two years ago and has aggressively in-licensed cancer treatments from Read More >

Inside BIO Industry Analysis  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , ,

See for Yourself: New BIO Book Showcases Visible Progress in Industrial Biotech

biofuel-plant-btn

BIO recently introduced a picture book of biorefineries across the United States, “Visible Progress in Commercialization of Advanced Biofuels, Biobased Products and Renewable Chemicals”, which showcases commercial, demonstration and even new pilot facilities. Some of these facilities have been in operation for as long as a decade while others are new plants under construction. They include the first commercial-scale cellulosic biofuel production biorefineries and facilities for ongoing research and development of industrial biotech products. Biorefineries Read More >

Biofuels & Climate Change  |  Leave a comment  |  Email This Post
Tags: , , , ,

Vaccines Beyond 2012

polio-vaccine

Each year, approximately 1.7 million children die from a vaccine-preventable disease, and the vast majority of these deaths occur in developing countries. This BIO 2012 session, moderated by Peg Willingham of the United Nations Foundation, addressed various ways industry can help increase access to life-saving vaccines for children and adults in resource-poor countries. The thoughts of a few of the speakers on the panel for this session are summarized below. The panelists suggested that for Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

Telling the Biotech Story at the BIO International Convention

convention-ribbon

The global event for biotechnology wrapped up last week at the Boston Convention & Exhibition Center in Boston, Mass. The event was a huge success, with a record 25,291 partnering meetings and hundreds of high-level speakers addressing critical global challenges and opportunities. More than 16,500 industry leaders from 49 states and 65 countries attended, yet again earning the title as the largest biotechnology event in the world. People are always asking for my perspective on our Convention, Read More >

Jim's Corner  |  1 Comment  |  Email This Post
Tags: , , , , ,

Biotech Food Labeling: Can Common Sense Prevail in Congress?

Wanzek

Terry Wanzek, North Dakota State Senator and farmer wrote an editorial for Truth About Trade & Technology about the continuing biotech labeling debate and efforts to inject anti-technology legislation into the Farm Bill: “The U.S. Senate wisely voted down a bad amendment to the Farm Bill last week, meaning that consumers won’t see their food bills skyrocket for no worthwhile reason.  So that’s good news.  Yet this is Washington, D.C., where the threat of harmful Read More >

Farmer Gene  |  Leave a comment  |  Email This Post
Tags: , , , , , ,